Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates
- PMID: 14966129
- DOI: 10.1074/jbc.M313691200
Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates
Abstract
Aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/IMP cyclohydrolase (ATIC) is a bifunctional enzyme with folate-dependent AICAR transformylase and IMP cyclohydrolase activities that catalyzes the last two steps of purine biosynthesis. The AICAR transformylase inhibitors BW1540 and BW2315 are sulfamido-bridged 5,8-dideazafolate analogs with remarkably potent K(i) values of 8 and 6 nm, respectively, compared with most other antifolates. Crystal structures of ATIC at 2.55 and 2.60 A with each inhibitor, in the presence of substrate AICAR, revealed that the sulfonyl groups dominate inhibitor binding and orientation through interaction with the proposed oxyanion hole. These agents then appear to mimic the anionic transition state and now implicate Asn(431') in the reaction mechanism along with previously identified key catalytic residues Lys(266) and His(267). Potent and selective inhibition of the AICAR transformylase active site, compared with other folate-dependent enzymes, should therefore be pursued by further design of sulfonyl-containing antifolates.
Similar articles
-
Structural insights into the avian AICAR transformylase mechanism.Biochemistry. 2002 Dec 31;41(52):15505-13. doi: 10.1021/bi020505x. Biochemistry. 2002. PMID: 12501179
-
Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis.Biochemistry. 2000 Sep 19;39(37):11303-11. doi: 10.1021/bi0007268. Biochemistry. 2000. PMID: 10985775
-
Structural insights into the human and avian IMP cyclohydrolase mechanism via crystal structures with the bound XMP inhibitor.Biochemistry. 2004 Feb 10;43(5):1171-83. doi: 10.1021/bi030162i. Biochemistry. 2004. PMID: 14756553
-
Evidence for the hypothesis that 10-formyldihydrofolate is the in vivo substrate for aminoimidazolecarboxamide ribotide transformylase.Exp Biol Med (Maywood). 2010 Mar;235(3):271-7. doi: 10.1258/ebm.2009.009151. Exp Biol Med (Maywood). 2010. PMID: 20404044 Review.
-
Modulation of the de novo purine nucleotide pathway as a therapeutic strategy in mitochondrial myopathy.Pharmacol Res. 2018 Dec;138:37-42. doi: 10.1016/j.phrs.2018.09.027. Epub 2018 Sep 26. Pharmacol Res. 2018. PMID: 30267763 Review.
Cited by
-
Classifying compound mechanism of action for linking whole cell phenotypes to molecular targets.J Mol Recognit. 2012 Apr;25(4):216-23. doi: 10.1002/jmr.2174. J Mol Recognit. 2012. PMID: 22434711 Free PMC article.
-
Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activity.J Med Chem. 2013 Dec 27;56(24):10016-10032. doi: 10.1021/jm401328u. Epub 2013 Dec 11. J Med Chem. 2013. PMID: 24256410 Free PMC article.
-
Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets.Pharmaceutics. 2021 Dec 21;14(1):10. doi: 10.3390/pharmaceutics14010010. Pharmaceutics. 2021. PMID: 35056904 Free PMC article. Review.
-
Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer.Front Endocrinol (Lausanne). 2022 May 19;13:813306. doi: 10.3389/fendo.2022.813306. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35663326 Free PMC article.
-
Novel 5-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase and as potential antitumor agents.J Med Chem. 2015 Feb 12;58(3):1479-93. doi: 10.1021/jm501787c. Epub 2015 Feb 2. J Med Chem. 2015. PMID: 25602637 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
